PR/SET Domain Family and Cancer: Novel Insights from The Cancer Genome Atlas
暂无分享,去创建一个
Ciro Abbondanza | Antonio Federico | A. Ciccodicola | A. Casamassimi | M. Rienzo | Antonio Federico | Maurizio Bifulco | M. Bifulco | P. Gazzerro | C. Abbondanza | A. Sorrentino | Alfredo Ciccodicola | Patrizia Gazzerro | Monica Rienzo | Amelia Casamassimi | Anna Sorrentino | A. Federico | Monica Rienzo
[1] M. Alcalay,et al. The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development , 2009, PloS one.
[2] S. Orkin,et al. FOG, a Multitype Zinc Finger Protein, Acts as a Cofactor for Transcription Factor GATA-1 in Erythroid and Megakaryocytic Differentiation , 1997, Cell.
[3] Ying Xim Tan,et al. The role of PRDMs in cancer: one family, two sides. , 2016, Current opinion in genetics & development.
[4] Yang Zhang,et al. The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.
[5] C. Napoli,et al. Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies , 2013, Clinical and Translational Oncology.
[6] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[7] A. Godzik,et al. Comparison of algorithms for the detection of cancer drivers at subgene resolution , 2017, Nature Methods.
[8] F. Ciccarelli,et al. Family expansion and gene rearrangements contributed to the functional specialization of PRDM genes in vertebrates , 2007, BMC Evolutionary Biology.
[9] E. Lander,et al. Lessons from the Cancer Genome , 2013, Cell.
[10] Jun Yu,et al. The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors , 2011, PloS one.
[11] F. Cole,et al. Missing the Mark: PRDM9-Dependent Methylation Is Required for Meiotic DSB Targeting. , 2018, Molecular cell.
[12] Lei Jiang,et al. RIZ1: a potential tumor suppressor in glioma , 2015, BMC Cancer.
[13] A. Ciccodicola,et al. Human PRDM2: Structure, function and pathophysiology. , 2018, Biochimica et biophysica acta. Gene regulatory mechanisms.
[14] Valerio Costa,et al. Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex , 2017, International journal of molecular sciences.
[15] L. Duret,et al. PRDM9 Methyltransferase Activity Is Essential for Meiotic DNA Double-Strand Break Formation at Its Binding Sites. , 2018, Molecular cell.
[16] A Mayakonda,et al. Maftools: Efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies , 2016, bioRxiv.
[17] G. Shao,et al. The PR Domain of the Rb-binding Zinc Finger Protein RIZ1 Is a Protein Binding Interface and Is Related to the SET Domain Functioning in Chromatin-mediated Gene Expression* , 1998, The Journal of Biological Chemistry.
[18] Peng-Fei Xu,et al. Genome-Wide Survey and Developmental Expression Mapping of Zebrafish SET Domain-Containing Genes , 2008, PloS one.
[19] Gad Getz,et al. Analysis of somatic microsatellite indels identifies driver events in human tumors , 2017, Nature Biotechnology.
[20] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[21] N. Yoo,et al. Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability , 2016, Pathology & Oncology Research.
[22] K. Quinlan,et al. The Identification and Structure of an N-Terminal PR Domain Show that FOG1 Is a Member of the PRDM Family of Proteins , 2014, PloS one.
[23] K. Kinzler,et al. Evaluating the evaluation of cancer driver genes , 2016, Proceedings of the National Academy of Sciences.
[24] Vivien Marx,et al. Cancer genomes: discerning drivers from passengers , 2014, Nature Methods.
[25] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[26] Pierre Kerner,et al. Evolution of Prdm Genes in Animals: Insights from Comparative Genomics , 2015, Molecular biology and evolution.
[27] Tobias Hohenauer,et al. The Prdm family: expanding roles in stem cells and development , 2012, Development.
[28] Steven P. Gygi,et al. Initiation of myoblast/brown fat switch through a PRDM16-C/EBP-β transcriptional complex , 2009, Nature.
[29] Yang Zhang,et al. I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.
[30] M. Kadota,et al. PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency , 2016, Stem cell reports.
[31] Guido Marcucci,et al. CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice. , 2016, Blood.
[32] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[33] C. Abbondanza,et al. PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation , 2013, Biology.
[34] Roded Sharan,et al. Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer , 2015, PLoS Comput. Biol..
[35] G. G. Galli,et al. PRDM proteins: important players in differentiation and disease. , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[36] P. Cohen,et al. The Multifaceted Roles of PRDM16: Adipose Biology and Beyond , 2016, Trends in Endocrinology & Metabolism.
[37] Tae Hoon Kim,et al. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. , 1999, Genes & development.
[38] Lana X. Garmire,et al. More Is Better: Recent Progress in Multi-Omics Data Integration Methods , 2017, Front. Genet..
[39] M. Sung,et al. A Macrohistone Variant Links Dynamic Chromatin Compaction to BRCA1-Dependent Genome Maintenance , 2014, Cell reports.
[40] B. Spiegelman,et al. PRDM16 controls a brown fat/skeletal muscle switch , 2008, Nature.
[41] I. Tomlinson,et al. The mini-driver model of polygenic cancer evolution , 2015, Nature Reviews Cancer.